Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.32724
Abstract: Randomized controlled trials (RCTs) have demonstrated that low‐dose direct oral anticoagulants (DOACs), including rivaroxaban and apixaban, may help reduce the incidence of cancer‐associated venous thromboembolism (VTE). read more here.
Keywords: low dose; direct oral; dose direct; cancer ... See more keywords
SAFETY AND EFFICACY OF LOW DOSE DIRECT ORAL ANTICOAGULANTS IN PATIENTS UNDERGOING CATHETER ABLATION
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)30856-8
Abstract: It is unclear about perioperative complication of atrial fibrillation (AF) patients underwent catheter ablation with low dose direct oral anticoagulants (DOACs). We considered the efficacy and safety of low dose DOACs for AF patients compared… read more here.
Keywords: low dose; oral anticoagulants; direct oral; catheter ablation ... See more keywords